Skip to main content

J&J Files Motion To Toss Oklahoma Opioid Lawsuit

J&J Files Motion To Toss Oklahoma Opioid Lawsuit

J&J Files Motion To Toss Oklahoma Opioid Lawsuit

Introduction

On July 3, 2019, Johnson & Johnson (J&J) filed a motion to seek dismissal of the Oklahoma opioid lawsuit on the grounds that the state failed to produce enough evidence to support its case. A final call, deciding whether to throw it out or to allow it to proceed is expected on Monday, July 8, when each party would have an hour each to argue its case before the judge. The drugmaker has asked Judge Thad Balkman to toss the case, claiming that the company has been made a "scapegoat" and the state's effort as legally illogical and defective. 

J&J and its subsidiaries have been accused of the opioid epidemic by Oklahoma Attorney General Mike Hunter. The state has presented a $17.5 billion abatement plan over 30 years to fix the opioid epidemic. Hunter also pointed out the fact that J&J once owned two subsidiaries in Tasmania, which supplied 60% of all active ingredients to the opioids manufacturers in the United States, including Purdue Pharma, manufacturer of the painkiller OxyContin.

More than 1,900 opioid lawsuits have been filed under MDL No. 2804 (In Re: National Prescription Opiate Litigation) which is presided by U.S. District Judge Dan Polster.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!